Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 7, 2008, Pages 1290-1295

  Luangrath, Vilayphone ^a   Brodeur, Mathieu R ^a   Rhainds, David ^b   Brissette, Louise ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

CD36; Cholesterol; LDL; Mouse; SR BI

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR B;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; CELL CULTURE; CONTROLLED STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIPID DEGRADATION; LIPID METABOLISM; LIPOLYSIS; LIVER CELL; MALE; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; KINETICS; METABOLISM; MOUSE MUTANT; PROTEIN BINDING;

ANIMALS; ANTIGENS, CD36; CELLS, CULTURED; CHOLESTEROL ESTERS; HEPATOCYTES; KINETICS; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; SCAVENGER RECEPTORS, CLASS B;

EID: 46249117031     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.161653     Document Type: Article

References (30)

1. Lilly SM, Rader DJ. New targets and emerging therapies for reducing LDL cholesterol. Curr Opin. Lipidol. 2007;18:650-655.
2. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification, of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996;271:518-520.
3. Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low density lipoprotein cholesteryl esters. Biochemistry. 2003;42:7527-7538.
4. Brodeur MR, Luangrath V, Bourret G, Falstrault L, Brissette L. Physio-logical importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice. J Lipid Res. 2005;46:687-696.
5. Connelly MA, Kellner-Weibel G, Rothblat GH, Williams DL. SR-BI-directed HDL-cholesteryl ester hydrolysis. J Lipid Res. 2003;44:331-341.
6. Van Berkel TJ, De Rijke YB, Kruijt JK. Different fate in vivo oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endo-thelial liver cells. J Biol Chem. 1991;266:2282-2289.
7. Ling W, Lougheed M, Suzuki H, Buchan A, Kodama T, Steinbrecher UP. Oxidized or acetylated low density lipoproteins are rapidly cleared by liver in mice with disruption of the scavenger receptor class A type I/II gene. J Clin Invest. 1997;100:244-252.
8. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
9. Rhainds D, Falstrault L, Tremblay C, Brissette L. Uptake and fate of class B scavenger receptor ligands in HepG2 cells. Eur J Biochem. 1999;26: 227-235.
10. Gillotte-Taylor K, Boullier A, Witztum JL, Steinberg D, Quehenberger O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res. 2001;42:1474-1482.
11. Bourret G, Brodeur MR, Luangrath V, Lapointe J, Falstrault L, Brissette L. In vivo cholesteryl ester selective uptake of mildly and standardly oxidized LDL occurs by both parenchymal and nonparenchymal mouse hepatic cells but SR-BI is only responsible for standardly oxidized. LDL selective uptake by nonparenchymal cells. Int J Biochem Cell Biol. 2006;38:1160-1170.
12. Febbraio M, Abumrad NA. Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein. RL. A null mutation, in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274: 19055-19062.
13. Rigotti A, Trigatti BL, Penman M, Raybum H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA. 1997;94: 12610-12615.
14. Lougheed M, Steinbrecher UP. Mechanism of uptake of copper-oxidized low density lipoprotein, in macrophages is dependent on its extent of oxidation. J Biol Chem. 1996;27:11798-11805.
15. Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res. 2003;44:2270-2277.
16. Seo T, Al-Haideri M, Treskova E, Worgall TS, Kako Y, Goldberg IJ, Deckelbaum RJ. Lipoprotein lipase-mediated selective uptake from, low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1. J Biol Chem. 2000;275: 30355-30362.
17. Swarnakar S, Beers J, Strickland DK, Azhar S, Williams DL. The apo-lipoprotein. E-dependent low density lipoprotein cholesteryl ester selective uptake pathway in murine adrenocortical cells involves chon-draitin sulfate proteoglycans and an alpha 2-macroglobulin receptor. J Biol Chem. 2001;276:21121-21128.
18. Berneis K, Rizzo M. LDL size: does it matter? Swiss Med Wkly. 2004; 134:720-724.
19. Pedreno J, de Castellarnau C, Cullare C, Ortin R, Sanchez JL, Llopart RL, Gonzalez-Sastre F. Platelet LDL receptor recognizes with the same apparent affinity both oxidized and native LDL. Arterioscler Thromb. 1994;14:401-408.
20. Brissette L, Charest MC, Falstrault L. Selective uptake of cholesteryl esters of low-density lipoproteins is mediated, by the lipopratein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem J. 1996;318:841-847.
21. Calvo D, Gómez-Coronado D, Suárez Y, Lasunción MA, Vega MA. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res. 1998;39:777-788.
22. Febbraio M, Silverstein RL. CD36: Implications in cardiovascular disease. Int J Biochem Cell Biol. 2007;39:2012-2030.
23. Febbraio M, Podřez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein. RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000;105:1049-1056.
24. Febbraio M, Guy E, Silverstein RL. Stem, cell transplantation, reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:2333-2338.
25. Guy E, Kuchibhotla S, Silverstein R, Febbraio M. Continued, inhibition of atherosclerotic lesion development in long term Western diet fed CD36°/apoE° mice. Atherosclerosis. 2007;192:123-130.
26. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atheroscle-rosis in hyperlipidemic mice. J Clin Invest. 2005;115:2192-2201.
27. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) glycoprotein IV on monocytes. Blood. 1994;83: 392-397.
28. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet. 2005;357: 686-687.
29. Yanai H, Chiba H, Morimoto M, Abe K, Fujiwara H, Fuda H, Hui SP, Takahashi Y, Akita H, Jamieson GA, Kobayashi K, Matsuno K. Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am. J Med Genet. 2000;93:299-304.
30. Yamashita S, Hirano K, Kuwasako T, Janabi M, Toyama Y, Ishigami M, Sakai N. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol Cell Biochem. 2007;299:19-22.